PMID: 6164924May 7, 1981Paper

gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC

Nature
W J CatalonaR E McCool

Abstract

Staphylococcus aureus produces a protein identified as protein A (SpA) with a molecular weight of 41,000 (ref. 1) which binds to the Fc region of many types of mammalian IgG2, activates complement, blocks opsonins and is both chemotactic and mitogenic. SpA has been used for various immunological purposes including removal of immune complexes, arming effector cells with antibody, distinguishing between antibody-dependent cell-mediated cytotoxicity (ADCC) and natural killing (NK), and exerting anti-tumor activity. We have now demonstrated that SpA induces the production of gamma interferon (IFN-gamma) in nonadherent, T lymphocyte-depleted (E-), Fc receptor-bearing (FcR+) human peripheral blood lymphocytes. Our data also suggest that IFN-gamma is a potent stimulator of both NK and ADCC activity.

References

Oct 1, 1979·Infection and Immunity·M P LangfordH M Johnson
May 15, 1978·International Journal of Cancer. Journal International Du Cancer·R L VessellaM E Kaplan
Jan 1, 1976·Scandinavian Journal of Immunology·A SulicaJ Sjöquist
Mar 1, 1976·European Journal of Immunology·A ForsgrenH Wigzell
Jun 1, 1970·The Journal of General Virology·H J Way, D J Garwes
Nov 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·R L HarveyR C Williams
Sep 25, 1972·European Journal of Biochemistry·I BjörkJ Sjöquist

❮ Previous
Next ❯

Citations

Jan 1, 1985·Cancer Chemotherapy and Pharmacology·P K RayD McLaughlin
Nov 1, 1985·Journal of Clinical Immunology·R L HirschK P Johnson
Jan 1, 1991·Cancer Immunology, Immunotherapy : CII·R A LindemannR K Gupta
Jul 14, 1999·Archives of Pharmacal Research·S Pyo, D K Rhee
Dec 1, 1994·International Journal of Immunopharmacology·S RaisuddinP K Ray
Jun 16, 1999·Immunology Letters·P SinhaP K Ray
Apr 1, 1997·Journal of Ethnopharmacology·B N Paul, A K Saxena
Jan 10, 2002·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·G MaticW Ramlow
May 4, 2001·Journal of Biomolecular Structure & Dynamics·J SenguptaG Basu
Apr 1, 1990·Journal of Interferon Research·J N IJzermansR L Marquet
May 2, 1986·European Journal of Biochemistry·T MoksM Uhlén
Mar 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan P ButcharSusheela Tridandapani
Feb 1, 1993·Journal of Neuroimmunology·Y Kuroda, M Matsui
Mar 31, 2010·International Journal of Peptide Research and Therapeutics·Riaz A Khan
Sep 26, 2001·Immunological Investigations·T K MondalP Pal
Feb 1, 1994·Immunopharmacology and Immunotoxicology·S I ZaidiP K Ray
Nov 1, 1995·Immunopharmacology and Immunotoxicology·S I ZaidiP K Ray
Jan 1, 1987·Immunopharmacology and Immunotoxicology·K P SinghP K Ray
Jan 1, 1987·Immunopharmacology and Immunotoxicology·A K PrasadP K Ray
Oct 1, 1983·Immunological Communications·P K Ray, S K Bandyopadhyay
Feb 24, 2001·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·R GuieuB Dussol
Jun 15, 1990·Biochemical and Biophysical Research Communications·P P DwivediP K Ray
Sep 1, 1987·European Journal of Cancer & Clinical Oncology·A JermyR C Rees

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.